Page last updated: 2024-09-03

c 1311 and Uterine Cervical Neoplasms

c 1311 has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustin, E; Chambers, TC; Chu, R; Fedejko-Kap, B; Mazerska, Z; Pawlowska, M; Radominska-Pandya, A	1

Other Studies

1 other study(ies) available for c 1311 and Uterine Cervical Neoplasms

Article	Year
Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:2 Topics: Acridines; Aminoacridines; Antineoplastic Agents; Biotransformation; Cell Survival; Dose-Response Relationship, Drug; Female; Glucuronides; Glucuronosyltransferase; HeLa Cells; Humans; Inhibitory Concentration 50; Transfection; Triazoles; Uterine Cervical Neoplasms	2013

Article

Year

Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:2

Topics: Acridines; Aminoacridines; Antineoplastic Agents; Biotransformation; Cell Survival; Dose-Response Relationship, Drug; Female; Glucuronides; Glucuronosyltransferase; HeLa Cells; Humans; Inhibitory Concentration 50; Transfection; Triazoles; Uterine Cervical Neoplasms

2013